Showing 2411-2420 of 2652 results for "".
- President of Glaucoma Research Foundation Issues Messagehttps://modernod.com/news/president-of-glaucoma-research-foundation-issues-message/2477429/The Glaucoma Research Foundation sent an email to its membership on Friday, answering questions that glaucoma specialists may have during the COVID-19 pandemic. The letter reads: Dear Friends, Your health and well-being are on our minds as we all deal with a national and glob
- First-Phase Clinical Trials of China’s First Covid-19 Vaccine to Last Nine Monthshttps://modernod.com/news/first-phase-clinical-trials-of-chinas-first-covid-19-vaccine-to-last-nine-months/2477423/Clinical trials of China’s first inoculation for Covid-19 will run until Dec. 31 this year, according to data made public by the Chinese Clinical Trial Registry, as rep
- Retina Specialists Share How They Are Adjusting to COVID-19https://modernod.com/news/retina-specialists-share-how-they-are-adjusting-to-covid-19/2477416/As the novel coronavirus outbreak continues to spread in the United States, retina clinics—who often see older patients who are more at risk of virus complications—are making a number of adjustments. Rishi P. Singh, MD, staff physician at the Cole Eye Institute at the Cleveland Clinic, whe
- Ribomic Enters License Agreement with AJU Pharma for RBM-007 in AMDhttps://modernod.com/news/ribomic-enters-license-agreement-with-aju-pharma-for-rbm-007-in-amd/2477400/Ribomic announced that it has signed a license agreement with Korean pharmaceutical company AJU Pharm Co. for RBM-007 for the indication of the exudative age-related macular degeneration (AMD) in the territory of Korea and Southeast Asia (Singapore, Philippines, Thailand, Vietnam, Indonesia, Mala
- The Outpatient Ophthalmic Surgery Society (OOSS) Releases Statement Regarding COVID-19 Outbreakhttps://modernod.com/news/ooss-releases-statement-regarding-covid-19-outbreak/2477392/The Outpatient Ophthalmic Surgery Society (OOSS) has released a statement to its membership providing information and resources on how to establish ASC procedures if your community is directly affected by the COVID-19 outbreak. The statement reads: Dear Colleagues, In the cu
- AGTC Announces Completion of Enrollment in All Adult Dose Groups of its Ongoing Phase 1/2 Clinical Trials in Patients with Achromatopsiahttps://modernod.com/news/agtc-announces-completion-of-enrollment-in-all-adult-dose-groups-of-its-ongoing-phase-1-2-clinical-trials-in-patients-with-achromatopsia/2477389/Applied Genetic Technologies Corporation (AGTC) announced that it has completed the planned enrollment in all dose groups for adult patients (age 18 years or older), including the two higher dose groups, of its phase 1/2 clinical programs with achromatopsia due to mutation in the
- Acuity Eye Group Offers Tips During National Nutrition Month For Better Visionhttps://modernod.com/news/acuity-eye-group-offers-tips-during-national-nutrition-month-for-better-vision/2477373/More and more evidence is showing that diet has an impact on every aspect of ones health, including vision. In honor of National Nutrition Month, doctors at Acuity Eye Group have tips and recommendations to eat your way to better vision. Research shows that a healthy diet and lifestyle wit
- Registration Now Open for Neuro-Optometric Rehabilitation Association (NORA) 2020 Annual Conferencehttps://modernod.com/news/registration-now-open-for-neuro-optometric-rehabilitation-association-nora-2020-annual-conference/2477365/Registration is now open for the Neuro-Optometric Rehabilitation Association, International (NORA) Clinical Skills Pre-Conference (September 10-11) and 29th annual General Conference (September 12-13) at the Hyatt Regency Columbus in Columbus, Ohio. “This year’s conference them
- Market Scope: New Cataract Atlas Identifies Location of Premium IOLs and High Volume Surgeonshttps://modernod.com/news/market-scope-new-cataract-atlas-identifies-location-of-premium-iols-and-high-volume-surgeons/2477348/The metro areas of New York, Los Angeles, Dallas, and Chicago account for 14 percent of the population over 60 in the US. However, on a per capita share basis, most of the metro areas in Florida stand out for their potential pool of cataract patients, driven largely by the state’s high median age
- Vision Expo East Announces Speakers and Experiences for The Bridge and Innovation Stagehttps://modernod.com/news/vision-expo-east-announces-speakers-and-experiences-for-the-bridge-and-innovation-stage/2477341/Vision Expo announced the series of events and speakers planned for The Bridge and Innovation Stage at the 2020 event in New York City. In keeping with Vision Expo’s renewed focus on discovery, experience, and connection, attendees can expect a robust lineup of industry experts, creative luminari